Hemostemix Capex To Depreciation from 2010 to 2024
| HEM Stock | CAD 0.08 0.01 5.88% |
Capex To Depreciation | First Reported 2010-12-31 | Previous Quarter 0.0206 | Current Value 0.0196 | Quarterly Volatility 1.42449 |
Check Hemostemix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hemostemix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 212, Interest Expense of 577.6 K or Selling General Administrative of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Hemostemix financial statements analysis is a perfect complement when working with Hemostemix Valuation or Volatility modules.
Hemostemix | Capex To Depreciation |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.